| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.28 | 0.3 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.057 | 0.3 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.3 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |